Paratek Pharmaceuticals, Inc. Business Finance Contracts & Agreements

First Supplemental Indenture, dated as of September 21, 2023, by and between the Company and U.S. Bank Trust Company, National Association (f/k/a U.S. Bank National Association),... (Filed With SEC on September 21, 2023)

Contribution and Servicing Agreement, dated as of December 31, 2020, by and between Paratek Pharmaceuticals, Inc., as Contributor, and PRTK SPV2 LLC, as Company (Filed With SEC on January 4, 2021)

Revenue Interest Purchase Agreement, dated as of December 31, 2020, by and between Paratek Pharmaceuticals, Inc., as Seller, and PRTK SPV2 LLC, as Company (Filed With SEC on January 4, 2021)

Loan Agreement, dated as of December 31, 2020, by and between R-Bridge Healthcare Cayman AIV, L.P., as Lender, and PRTK SPV2 LLC, as Borrower (Filed With SEC on January 4, 2021)

First Amendment to the 2019 Amended and Restated Loan and Security Agreement, dated August 5, 2020, by and among Paratek Pharmaceuticals, Inc., Paratek Pharma, LLC, certain... (Filed With SEC on August 10, 2020)

Warrant Agreement, dated as of August 5, 2020 issued to Hercules Capital, Inc (Filed With SEC on August 10, 2020)

Amended and Restated Loan and Security Agreement, dated June 27, 2019, by and among Paratek Pharmaceuticals, Inc., Paratek Pharma, LLC, Hercules Technology III and certain other... (Filed With SEC on July 2, 2019)

2018 Employee Stock Purchase Plan, as amended (Filed With SEC on November 6, 2018)

Amendment No. 5 to Loan and Security Agreement dated August 1, 2018, by and between Paratek Pharmaceuticals, Inc., Paratek Pharma, LLC, Hercules Technology II, L.P., Hercules... (Filed With SEC on August 2, 2018)

Warrant Agreement, dated August 1, 2018 issued to Hercules Capital, Inc. Form 8-K 001-36066 4.1 June 29, 2017 4.6 Warrant, dated as of April 7, 2014 issued to HBM Healthcare... (Filed With SEC on August 2, 2018)

Paratek Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on June 18, 2018)

Amendment No.4 to the Loan and Security Agreement, as amended, with Hercules Technology II, L.P., Hercules Technology III, L.P. and certain other lenders, and Hercules Technology... (Filed With SEC on April 23, 2018)

Indenture, dated as of April 23, 2018, by and between Paratek Pharmaceuticals, Inc. and U. S. Bank National Association (including the form of the 4.75% Convertible Senior... (Filed With SEC on April 23, 2018)

Purchase Agreement, dated as of April 18, 2018, among Paratek Pharmaceuticals, Inc. and the several Initial Purchasers named in Schedule A thereto for whom Merrill Lynch, Pierce,... (Filed With SEC on April 23, 2018)

Underwriting Agreement, dated January 17, 2018, between Paratek Pharmaceuticals, Inc. and BTIG, LLC (Filed With SEC on January 19, 2018)

Amendment No. 3 to Loan and Security Agreement dated June 27, 2017, by and between Paratek Pharmaceuticals, Inc., Paratek Pharma, LLC, Hercules Technology II, L.P., Hercules... (Filed With SEC on June 29, 2017)

Form of Warrant (Filed With SEC on June 29, 2017)

Paratek Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice (2017 Inducement Plan) (Filed With SEC on June 16, 2017)

Paratek Pharmaceuticals, Inc. Stock Option Grant Notice (2017 Inducement Plan) (Filed With SEC on June 16, 2017)

AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 2, 2017)

Paratek Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 2, 2017)

AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 13, 2016)

FORM OF WARRANT AGREEMENT To Purchase Shares of the Common Stock of PARATEK PHARMACEUTICALS, INC. Dated as of ____________ (the Effective Date) (Filed With SEC on December 13, 2016)

PARATEK PHARMACEUTICALS, INC. (aDelaware corporation) 4,250,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 22, 2016)

PARATEK PHARMACEUTICALS, INC. Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on October 15, 2015)

STOCK PURCHASE AGREEMENT (Filed With SEC on October 5, 2015)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of PARATEK PHARMACEUTICALS, INC. Dated as of _______________ (the Effective Date) (Filed With SEC on October 5, 2015)

PARATEK PHARMACEUTICALS, INC. (aDelaware corporation) 2,860,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 30, 2015)

PARATEK PHARMACEUTICALS, INC. WARRANT TO PURCHASE SERIES A PREFERRED STOCK (Filed With SEC on April 2, 2015)

WARRANT AGREEMENT To PurchaseShares of the Series C Preferred Stock of TransOral Pharmaceuticals, Inc. Dated as of April 13, 2006 (the Effective Date) (Filed With SEC on April 2, 2015)

PARATEK PHARMACEUTICALS, INC. 2015 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on February 10, 2015)

LOAN AND SECURITY AGREEMENT (Filed With SEC on November 19, 2012)

WARRANT TO PURCHASE STOCK (Filed With SEC on November 19, 2012)

INVESTOR RIGHTS AGREEMENT (Filed With SEC on September 27, 2012)

TRANSCEPT PHARMACEUTICALS, INC. (a Delaware corporation) 4,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 26, 2012)

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 14, 2010)

TRANSCEPT PHARMACEUTICALS, INC. 2009EMPLOYEE STOCK PURCHASE PLAN ADOPTED BYTHE BOARD OF DIRECTORS: APRIL 3, 2009 APPROVED BY THE STOCKHOLDERS: JUNE 3, 2009 (Filed With SEC on June 9, 2009)

Category

Industry

Companies

Contracts

Paratek Pharmaceuticals, Inc. Business Finance Contracts & Agreements